Publikationen in Zusammenarbeit mit Forschern von Universidad de Granada (24)

2023

  1. Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain

    Annals of Hematology, Vol. 102, Núm. 2, pp. 447-456

2022

  1. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86

  2. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 4, pp. 238-250

  3. Clozapine-induced myocarditis in Russia: Animal studies but no clinical studies

    Revista de Psiquiatria y Salud Mental

  4. Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))

    Pharmacopsychiatry

  5. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  6. Telepsychiatry: The future is already present

    Revista de Psiquiatria y Salud Mental

2021

  1. An update on the complex relationship between clozapine and pneumonia

    Expert Review of Clinical Pharmacology

  2. Effect of necessity-concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample

    Human Psychopharmacology, Vol. 36, Núm. 4

2020

  1. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology

    Psychotherapy and Psychosomatics, Vol. 89, Núm. 4, pp. 200-214

  2. Self-report for measuring and predicting medication adherence: experts’ experience in predicting adherence in stable psychiatric outpatients and in pharmacokinetics

    Patient Preference and Adherence, Vol. 14, pp. 1823-1842

  3. The necessity-concern framework in the assessment of treatment adherence of psychiatric patients and the role of polypharmacy in a Spanish sample

    Human Psychopharmacology, Vol. 35, Núm. 1

2019

  1. A clinimetric approach for improving the measurement of pharmacophobia with replication in two other samples

    Psychotherapy and Psychosomatics

  2. Biological and prognostic differences between symptomatic colorectal carcinomas and those detected by screening

    European Journal of Surgical Oncology, Vol. 45, Núm. 10, pp. 1876-1881

  3. Development and validation of the patient’s health belief questionnaire on psychiatric treatment

    Patient Preference and Adherence, Vol. 13, pp. 527-536

  4. Ethnopsychopharmacology study of patients' beliefs regarding concerns about and necessity of taking psychiatric medications

    Human Psychopharmacology, Vol. 34, Núm. 2

  5. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  6. Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

    PLoS ONE, Vol. 14, Núm. 11

  7. Referral of Patients to Dermatology and Teledermatology Consultations in Spain. DIADERM Study

    Actas Dermo-Sifiliograficas, Vol. 110, Núm. 2, pp. 146-152

2018

  1. Skepticism and pharmacophobia toward medication may negatively impact adherence to psychiatric medications: A comparison among outpatient samples recruited in Spain, Argentina, and Venezuela

    Patient Preference and Adherence, Vol. 12, pp. 301-310